Home » Topics » Regulatory

Regulatory
RSS

TheraTech joins forces with Meiji and Sankyo to develop and market oxybutynin patch

Oct. 10, 1997

Pamidronate evaluated as potential therapy for bone cancer

Oct. 9, 1997

Celgene studies chirally pure mexiletine for relief of neuropathic pain

Oct. 9, 1997

Mylan receives FDA approval for generic verapamil

Oct. 9, 1997

Geref cleared for pediatric growth disorders in U.S.

Oct. 8, 1997

First approval for Infergen

Oct. 8, 1997

Knoll receives FDA approval for Vicoprofen

Oct. 7, 1997

NTZ: a potential new anti-H. pylori agent

Oct. 7, 1997

HMR and Andrx agree to stipulation in Cardizem CD patent lawsuit

Oct. 7, 1997

Nasonex Nasal Spray cleared for marketing in U.S.

Oct. 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...